Effect of cefixime and cefdinir, oral cephalosporins, on cytochrome P450 activities in human hepatic microsomes

被引:15
|
作者
Niwa, T
Shiraga, T
Hashimoto, T
Kagayama, A
机构
[1] Fujisawa Pharmaceut Co Ltd, Biopharmaceut & Pharmacokinet Res Labs, Yodogawa Ku, Osaka 5328514, Japan
[2] Fujisawa Pharmaceut Co Ltd, Postmarketing Dev Res Ctr, Chuo Ku, Osaka 5418514, Japan
关键词
cefixime; cefdinir; human hepatic cytochrome P450; oral cephalosporin; drug interaction;
D O I
10.1248/bpb.27.97
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of two kinds of oral cephalosporins, cefixime and cefdinir, on cytochrome P450 (CYP) activities in human hepatic microsomes were investigated. Both cefixime and cefdinir at 2 mm concentration neither inhibited nor stimulated CYP1A1/2-mediated 7-ethoxyresorufin O-deethylation, CYP2A6-mediated coumarin 7-hydroxylation, CYP2B6-mediated 7-benzyloxyresorufin O-debenzylation, CYP2C8/9-mediated tolbutamide methylhydroxylation, CYP2C19-mediated S-mephenytoin 4'-hydroxylation, CYP2D6-mediated bufuralol 1-hydroxylation, CYP2E1-mediated chlorzoxazone 6-hydroxylation, CYP3A4-mediated nifedipine oxidation, or CYP3A4-mediated testosterone 6beta-hydroxylation. The free fractions of cefixime and cefdinir in the incubation mixture, which were measured by ultracentrifugation, were 86.1-93.8% and 94.1-97.8%, respectively. These results suggest that both cefixime and cefdinir would not cause clinically significant interactions with other drugs, which are metabolized by CYPs, via the inhibition of metabolism.
引用
收藏
页码:97 / 99
页数:3
相关论文
共 50 条
  • [1] Effect of nilvadipine, a dihydropyridine calcium antagonist, on cytochrome P450 activities in human hepatic microsomes
    Niwa, T
    Shiraga, T
    Hashimoto, T
    Kagayama, A
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (03) : 415 - 417
  • [2] Effect of γ-oryzanol on cytochrome p450 activities in human liver microsomes
    Umehara, K
    Shimokawa, Y
    Miyamoto, G
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (07) : 1151 - 1153
  • [3] Effect of probucol on cytochrome P450 activities in human liver microsomes
    Umehara, K
    Shimokawa, Y
    Miyamoto, G
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (08) : 1112 - 1114
  • [4] Effect of cyclosporine and tacrolimus on cytochrome P450 activities in human liver microsomes
    Niwa, Toshiro
    Yamamoto, Sachiko
    Saito, Miho
    Shiraga, Toshifumi
    Takagi, Akira
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 (01): : 209 - 216
  • [5] Activities of human recombinant cytochrome P450 isoforms and human hepatic microsomes for the hydroxylation ofAlternaria toxins
    Pfeiffer E.
    Burkhardt B.
    Altemöller M.
    Podlech J.
    Metzler M.
    Mycotoxin Research, 2008, 24 (3) : 117 - 123
  • [6] Inhibitory effect of honokiol and magnolol on cytochrome P450 enzyme activities in human liver microsomes
    Joo, Jeongmin
    Liu, Kwang-Hyeon
    MASS SPECTROMETRY LETTERS, 2013, 4 (02) : 34 - 37
  • [7] Intraindividual Variation and Correlation of Cytochrome P450 Activities in Human Liver Microsomes
    Fang, Yan
    Gao, Jie
    Wang, Tong
    Tian, Xin
    Gao, Na
    Zhou, Jun
    Zhang, Hai-Feng
    Wen, Qang
    Jin, Han
    Xing, Yu-Rong
    Qiao, Hai-Ling
    MOLECULAR PHARMACEUTICS, 2018, 15 (11) : 5312 - 5318
  • [8] A comparison of cytochrome P450 activities in bactosomes, supersomes, and human liver microsomes
    Settle, K
    Madan, A
    Ogilvie, B
    Carrott, P
    Hussain, A
    Parkinson, A
    DRUG METABOLISM REVIEWS, 2002, 34 : 105 - 105
  • [9] Effect of Bakumondo-to on cytochrome P450 activities in rat liver microsomes
    Yasuhara, Masako
    Tayama, Yoshitaka
    Kashiwagi, Takehiro
    Sawa, Akihiro
    Kihira, Kenji
    Miyake, Katsushi
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2016, 28 (02) : 198 - 202
  • [10] Comparison of mouse and human cytochrome P450 mediated-drug metabolising activities in hepatic and extrahepatic microsomes
    Uehara, Shotaro
    Murayama, Norie
    Higuchi, Yuichiro
    Yoneda, Nao
    Yamazaki, Hiroshi
    Suemizu, Hiroshi
    XENOBIOTICA, 2022, 52 (03) : 229 - 239